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Abstract
Background: In ayurvedic and Thai traditional medicine, the fruit of T. chebula is useful in arthritic disorders, inflammation, tumor, pains, chronic
and recurrent fever. The study investigated the analgesic and anti-inflammatory activities in animal models.
Materials and methods: The water extract of T. chebula fruit was prepared and pain induced in mice by 0.1% formalin, before testing for the
analgesic activity of the extract. The anti-inflammatory study was conducted in rats using four experimental models; ethyl phenylpropiolate or
arachidonic acid-induced ear edema, carrageenan-induced paw edema and cotton pellet-induced granuloma formation.
Results: The T. chebula extract decreased licking times in mice injected with 0.1% formalin in both the early and late phases. Moreover, the extract
inhibited rat ear edema induced by ethyl phenylpropiolate as well as in carrageenan-induced paw edema. In contrast, the extract did not have any
inhibitory effect on arachidonic acid-induced ear edema in rats. The T. chebula extract did not reduce granuloma weight, body weight gain and thymus
dry weight in cotton pellet-induced granuloma formation.
Conclusion: These results likely suggest that T. chebula water extract possess both analgesic and anti-inflammatory activities. The main mechanisms
of action of T. chebula water extract may be due to the inhibitory effect on the synthesis and/or release of pain or inflammatory mediators
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Introduction
Terminalia chebula Retz, family Combretaceae, is known as “Sa Maw Thai” in Thailand. T. chebula tree is medium-sized or large, attaining
a height of up to 30 meter, with wide spreading branches and a broad roundish crown. The leaves are glabrous with a yellowish pubescence below.
The flowers are monoecious, dull white to yellow. They are terminal spikes or short panicles and have a strong unpleasant odor. The fruits are usually
smooth or frequently 5-ridged, ellipsoid to ovoid drupes, and yellow to orange brown in color, (Department of Medical Sciences, 2000) as shown in
Figure 1.
Figure 1: Terminalia chebula Retz.
In ayurvedic and Thai traditional medicine, the fruit of T. chebula has been extensively used for astringent, carminative, expectorant,
laxative, and tonic agents (Department of Medical Sciences, 2000). They are useful for treating arthritic disorders, inflammation, tumor, pains, chronic
and recurrent fever. The water extract from dried fruits of T. chebula has several pharmacological activities in both in vitro and in vivo tests, such as
antioxidant (Naik et al., 2004; Cheng et al., 2003; Lee et al., 2005, 2007), antibacterial (Malekzadeh et al., 2001; Bonjar 2004; Kim et al., 2006),
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antifungal (Dutta et al., 1998), antiviral (Yukawa et al., 1996; el-Mekkawy et al., 1995), and antimutagenic activities (Naik et al., 2004). Moreover, the
oral administration of the T. chebula water extract did not produce both acute and chronic toxicities in female and male rats (Panunto et al., 2011).
However, analgesic and anti-inflammatory activities of this plant have not been experimentally reported. Therefore, the objective of this study was to
evaluate the analgesic and anti-inflammatory activities of the water extract from dried fruit of T. chebula in animal models.
Materials and methods
Plant material and Preparation of plant extract
Ripe fruits of T. chebula were collected from the forest at a joint in Soengsang district, Nakorn Rajsrima province and Prakam district,
Buriram province, Thailand. The plant was identified and a voucher specimen number (PBM 00485) was deposited at Faculty of Pharmacy, Mahidol
University, Bangkok, Thailand. The method of preparation was described as follows: 68 kg of T. chebula fruits were boiled for 1 hr, filtered, and then
repeated 3 times. The extract was spray dried to remove trace of water T. chebula water extract was stored at -20 C after preparation.
Standardization of plant extract
The water extract of T. chebula was tested for quality control such as physical appearance, percentage of loss on dryness, total ash, acid
insoluble ash, microbial test, aflatoxin test, heavy metal, and quantity of chemical compounds (percentages of tannins, total carbohydrate, uronic acid,
and gallic acid), according to Thai Herbal Pharmacopoeia (Department of Medical Sciences, 2000). The extract was standardized by thin layer
chromatography (TLC) and high performance liquid chromatography (HPLC).
Experimental animals
Male Sprague-Dawley rats, weighing 40-60, 100-120, and 200-250 g as well as male ICR mice weighing 30-40 g were obtained from the
National Laboratory Animal Center, Nakorn Pathom, Thailand. They were housed under standard environmental conditions and temperature at 24±1
C under a 12 hr dark-light cycle, and allowed free access to drinking water and standard pellet diet. Rats were deprived of food except water 16-18
hour prior the experiments. The Animal Ethics Committee of Faculty of Medicine, Thammasat University approved all experimental protocols (No.
0001/2006).
Formalin test (Hunskaar and Hole, 1987)
Mice weighing (40-60 g) were used in this test. Each group of mice was orally administered with T. chebula extract at the doses of 150, 300
and 600 mg/kg, and aspirin (reference drug, 300 mg/kg). An hour later, the early phase assessment was conducted by subcutaneously injecting 20 l
of 1% formalin in saline solution into the right dorsal hind paw of the mouse. Then, between 0 and 5 min after formalin injection, the time in seconds
the mouse spent for intensive licking the right dorsal hind paw was recorded. In the late phase assessment, another set of mice was used. The formalin
was injected after the test drug administration for 40 min and the licking time was determined between 20 and 30 min after the formalin injection.
Ethyl phenylpropiolate (EPP)-induced ear edema in rats (Brattsand et al., 1982)
Male rats of 40–60 g were divided into 4 groups (n=6). The EPP was dissolved in acetone. Ear edema was induced by topical application of
EPP at the dose of 1 mg/20 l/ear to the inner and outer surfaces of both ears using an automatic microliter pipette. T. chebula extract dissolved in a
mixture of dimethylsulfoxide and acetone (1:1) was administered topically at the dose of 1, 2 and 4 mg/20 l/ear before the EPP application.
Phenulbutazone (reference drug) was administered topically at the dose of 1 mg/20 l/ear. The thickness of each ear was measured using vernier
calipers before and at 15, 30, 60 and 120 min after EPP induction.
Arachidonic acid (AA)-induced ear edema in rats (Young et al., 1984)
The procedure was similar to that previously described in EPP-induced ear edema model. T. chebula extract was administered topically at
the dose of 1, 2 and 4 mg/20 l/ear. The reference drugs, phenulbutazone and phenidone, were administered topically at the dose of 1 mg/20 l/ear.
AA was dissolved in acetone, and the ear edema was induced by topical application of AA at a dose of 2 mg/20 l/ear. The thickness of each ear was
measured at 60 min after AA induction.
Carrageenan-induced hind paw edema in rats (Winter et al., 1962)
Male rats weighing 100–120 g were divided into 5 groups of 6 rats. Paw edema was induced by an intradermal injection of carrageenan (1%
in normal saline solution) into the plantar surface of the right hind paw of the rats at a volume of 0.05 ml. The edema volume was determined using a
plethysmometer (model 7140, Ugo Basile, Italy) prior to and 1, 3 and 5 hr after carrageenan injection. T. chebula extract at the doses of 150, 300 and
600 mg/kg and aspirin (reference drug, 300 mg/kg) were given 1 hr prior to carrageenan injection.
Cotton pellet-induced granulation formation in rats (Swingle and Shideman, 1972)
Male rats weighing 200–250 g were divided into 4 groups of 6 rats. The T. chebula extract (600 mg/kg), aspirin (300 mg/kg) and
prednisolone (5 mg/kg) were orally given 1 hr before subcutaneous implantation of the cotton pellet. Under ether anesthesia, sterile cotton pellets
(201 mg) were implanted subcutaneously in both the axilla region of each rat through a single needle incision, one on each side. Test substances were
given once daily for seven consecutive days. On the 8th day, the rats were sacrificed and the pellets covered with granulation tissue and thymus were
dissected out, and weighed immediately for the wet weight. Cotton pellet and thymus were dried at 60 C for 18 hr and their dry weight was
determined. The change in body weight from the first and last day of experiment was also recorded. The increase in dry weight of the pellets was
taken as the measure of granuloma formation.
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Statistical analysis
Results were expressed as mean ± standard error of mean (S.E.M.). Statistical significance was determined by one-way analysis of variance
(ANOVA) and Dunnett test P values less than 0.05 were considered significant.
Results
T. chebula water extract
The contents of quality inspection items such as total ash, acid-insoluble ash, loss on drying, tannins and gallic acid were analyzed in both
raw material and the water extract of T. chebula fruit as shown in Table 1. The extraction yield as the percentage of the weight of the crude extract to
the raw material was 9.62%. Chemical compounds screening found flavonoids, hydrolysable tannin, terpenes, and blue fluorescence compounds.
Both raw material and the extract had no contamination of aflatoxin, pesticide, heavy metal and microbes.
Table 1: Quality control status of the raw material and the water extract of T. chebula fruit
Raw material Water extract
% Loss on drying 7.8548 2.9592
% Total ash 3.5615 3.9694
% Acid insoluble ash 0.4094 0.1552
% Tannins 24.67 60.00
% Gallic acid 0.67 4.37
Effect on formalin test in mice
T. chebula extract at the doses of 150, 300 and 600 mg/kg body weight significantly inhibited the licking response in the early phase and
markedly in the late phases. As positive control, aspirin at a dose 300 mg/kg as well as morphine (10 mg/kg) could intensively inhibit the licking
response in both phases. Although the effect of aspirin in the early phase was slight, the licking time was significantly reduced (Table 2).
Table 2: Analgesic activity of T. chebula extract on the formalin test in mice
Group Dose (mg/kg) Licking time (sec) % inhibition
Early phase
Control - 93.7±2.9 -
Aspirin 300 79.0±5.5* 15
Morphine 10 0.0±0.0* 100
T. chebula extract 150 70.7±4.7* 24
300 66.8±5.7* 29
600 57.0±7.5* 39
Late phase
Control - 64.5±17.0 -
Aspirin 300 0.0±0.0* 100
Morphine 10 0.0±0.0* 100
T. chebula extract 150 35.5±15.2* 45
300 22.2±8.0* 66
600 12.0±9.2* 81
Data represent mean ± S.E.M. (n=6). *Significantly different from the control group, p<0.05
Effect on EPP or AA-induced ear edema in rats
T. chebula extract at the dose of 1, 2 and 4 mg/ear exerted an inhibitory effect on the ear edema formation induced by EPP (Table 3), but not
on the AA-induced ear edema (Table 4).
Table 3: Effects of T. chebula extract on ethyl phenylpropiolate (EPP)-induced ear edema formation in rats
Group Dose Time after topical application of EPP
(mg/ear) 15 min 30 min 60 min 120 min
Control - 91.7  4.8 153.3  8.8 185.0  13.3 128.3  6.5
Phenylbutazone 1 33.3  11.1* 46.7  8.0* 68.3  6.5* 55.0  5.0*
T. chebula extract 1 61.7  6.0* 101.7  12.2* 115.0  12.3* 81.7  13.5*
2 50.0  4.5* 85.0  12.3* 91.7  9.4* 60.0  8.2*
4 43.3  2.1* 63.3  4.2* 81.7  7.5* 50.0  5.2*
Data represent mean ± S.E.M. (n=6). *Significantly different from the control group, p<0.05
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Table 4: Effects of T. chebula water extract on arachidonic acid (AA)-induced ear edema formation in rats
Group Dose
(mg/ear)
Edema thickness (m)
Control - 128.3  17.0
Phenylbutazone 1 66.7  15.8*
Phenidone 2 56.7  9.2*
T. chebula extract 1 96.7  18.9
2 103.3  10.5
4 128.3  14.2
Data represent mean ± S.E.M. (n=6). *Significantly different from the control group, p<0.05
Effect on carrageenan-induced paw edema in rats
As illustrated in Figure 1, T. chebula water extract at all doses of 150, 300 and 600 mg/kg reduced the paw edema after carrageenan
injection for 1-5 hr. The reference drug, aspirin at the dose of 300 mg/kg, also showed a significant inhibitory effect of the paw edema.
Figure 2: Effects of T. chebula water extract on carrageenan-induced paw edema in rat. *Significantly different from the control group, p<0.05.
Effects on cotton pellet-induced granuloma formation in rats
T. chebula water extract at 600 mg/kg and aspirin (300 mg/kg), dosage did not reduce transudative weight, granuloma formation, body
weight gain and thymus weight whereas the group treated daily with prednisolone (5 mg/kg) for 7 days elicited a marked inhibition of these
parameters (Tables 6 and 7).
Table 6: Effect of T. chebula water extract on transudative weight and granuloma formation of cotton pellet-induced granuloma formation in rats
Group Dose
(mg/kg)
Granuloma wet
weight (mg)
Granuloma dry
weight (mg)
Transudative
weight (mg)
Granuloma weight
(mg/mg cotton)
Control - 466.1  9.4 77.4  2.8 388.9  8.3 2.87  0.1
Prednisolone 5 350.9  7.1* 63.7  2.2* 287.1  5.7* 2.19  0.1*
Aspirin 300 449.7  12.2 75.9  2.1 373.7  11.0 2.80  0.1
T. chebula extract 600 447.2  17.4 74.3  4.5 372.8  14.4 2.72  0.2
Data represent mean ± S.E.M. (n=6). *Significantly different from the control group, p<0.05
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Table 7: Effect of T. chebula water extract on body weight and dry thymus weight of cotton pellet-induced granuloma formation in rats
Body weight (g)Group Dose
(mg/kg) Initial Final Gain
Dry thymus
weight (mg/100g)
Control 240.8  18.2 269.1  15.7 28.3  3.5 47.7  4.5
Prednisolone 5 205.8  17.3 221.6  13.2* 15.8  4.3* 35.1  4.2*
Aspirin 300 234.1  14.2 253.3  14.9 19.1  2.3 50.0  5.9
T. chebula extract 600 202.5  11.1 230.8  12.0 28.3  3.0 52.2  3.1
Data represent mean ± S.E.M. (n=6). *Significantly different from the control group, p<0.05
Discussion
In ayurvedic and Thai traditional medicine, the fruit of T. chebula has been reported for astringent, carminative, expectorant, laxative, and
tonic effects. This plant has been long used for the treatment of arthritic disorders, inflammation, tumor, pains, chronic and recurrent fever. In our
study, the analgesic and anti-inflammatory effects of the water extract from the fruit of T. chebula were demonstrated using several experimental
models in rats and mice.
The formalin test is a reliable model of pain which involves two distinct phases. A neurogenic pain corresponds to the early phase, followed
by an inflammatory pain that is conducted by the release of inflammatory mediators designated as late phase (Dubuisson and Dennis, 1977; Hunskaar
et al., 1985; Hunskaar and Hole, 1987). In this study, T. chebula water extract exhibited the analgesic activity in both phases of the formalin test, but
was more remarkable on the late phase. These results suggested that the principal mechanism of analgesic effects of T. chebula extract may be due to
the inhibition of the synthesis and/or release of inflammatory pain mediators such as prostaglandins and other mediators at peripheral nociception
sites. Moreover, the analgesic activity of T. chebula water extract may be partly active as well.
Inflammation occurs as a result of defensive response to eliminate the initial cause of cell injury as well as the necrotic cell and tissue
resulting from the original assault. Inflammatory reaction produces the synthesis and release of the inflammatory mediators, such as histamine,
bradykinin, PGs, IL-1 and TNF-α, with effects are related to pain and fever (Engblom et al., 2002; Ivanov and Romanovsky, 2004).  
Rat ear edema induced by EPP or AA is generally a useful model for rapid in vivo screening of anti-inflammatory activity. EPP causes the
release of many inflammatory mediators such as kinin, serotonin and PGs (Brattsand et al., 1982). AA-induced ear inflammation in mice has been
reported to be sensitive in detecting the anti-inflammatory action of lipoxygenase inhibitors (Young et al., 1984; Carlson et al., 1985). In this study, T.
chebula extract inhibited the ear edema induced by EPP, but not on the AA-induced ear edema. These results suggested that T. chebula possibly
inhibits the inflammatory mediators of the acute phase of inflammation, but does not involve the lipoxygenase pathway.
Carrageenan-induced paw edema is a predictive test for orally active anti-inflammatory agents acting by the mediators of acute
inflammation (Di Rosa et al., 1971; Mossa et al., 1995). This model involves the synthesis or release of mediators at the injured site including
prostaglandins, especially the E series, histamine, bradykinins, leukotrienes and serotonin (Asongalem et al., 2004). T. chebula water extract exhibited
a significant inhibitory effect on the paw edema induced by carrageenan. This observation indicated that T. chebula extract can be effective to alleviate
acute inflammatory disorders. The possible mechanism of action of T. chebala extract may result from the inhibition of prostaglandins synthesis and
the other inflammatory mediators.
The inflammatory granuloma is a typical feature of established chronic inflammatory reaction (Spector, 1969). The subcutaneously
implanted cotton pellet in rat is generally used to evaluate the interfering capacity of agents on the proliferative phases of inflammatory process. The
response to a subcutaneously implanted cotton pellet has been reported to involve a host inflammatory response (Remes and Williams, 1992; Tang and
Eaton, 1995; Hu et al., 2001), which can be divided into at least three phases, transudative, exudative and proliferative phases (Swingle and Shideman,
1972). Non-steroidal anti-inflammatory drugs, such as aspirin, elicit only a slight inhibition whereas steroidal anti-inflammatory drugs have a strong
inhibition on both transudative and proliferative phase of inflammation (Swingle and Shideman, 1972). In this study, T. chebula extract did not reduce
transudative weight, granuloma formation, body weight gain and thymus weight. The obtained results indicated that T. chebula water extract does not
have the steroidal-like activity.
In conclusion, the water extract from the fruits of T. chebula significantly reduced both the licking time in formalin test and the formation of
edema induced by ethyl phenylpropiolate and carrageenan. The T. chebula extract exhibited analgesic and anti-inflammatory activities. The main
mechanisms of action of T. chebula extract may be due to the inhibitory effect on the synthesis and/or release of pain or inflammatory mediators and
the analgesic activity may be partly centrally acting.
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